NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.21 +0.83 (+1.06%) GOLD FUTURES
2,316.40 -7.80 (-0.34%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,351.15 -1,064.54 (-2.11%)
Travere Therapeutics, Inc. (TVTX)
After hours:
| Previous close | 6.75 |
| Open | 6.77 |
| Bid | 6.79 x 500 |
| Ask | 6.86 x 200 |
| Day's range | 6.49 - 6.93 |
| 52-week range | 5.12 - 19.54 |
| Volume | |
| Avg. volume | 1,267,952 |
| Market cap | 519.2M |
| Beta (5Y monthly) | 0.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.41 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.13 |
GlobeNewswireTravere Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences: BofA Securities Health Care Conference Wednesday, May 15, 2024, at 8:00 a.m. PT Jefferies Global Healthcare ConferenceWednesday, June 5, 2024, at 3:00 p.m. ET Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will b
Simply Wall St.Loss-Making Travere Therapeutics, Inc. (NASDAQ:TVTX) Expected To Breakeven In The Medium-Term
With the business potentially at an important milestone, we thought we'd take a closer look at Travere Therapeutics...
- GuruFocus.com
Travere Therapeutics Inc (TVTX) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...
Discover how Travere Therapeutics Inc (TVTX) achieved a robust revenue increase and navigated regulatory landscapes in the first quarter of 2024.
